| 1 |
31285943 | Decontamination methods to restore the biocompatibility of contaminated titanium surfaces. | 2019 Jun |
1 |
| 2 |
22743615 | LTBP-2 confers pleiotropic suppression and promotes dormancy in a growth factor permissive microenvironment in nasopharyngeal carcinoma. | 2012 Dec 1 |
1 |
| 3 |
18333801 | Regulable vascular endothelial growth factor165 overexpression by ex vivo expanded keratinocyte cultures promotes matrix formation, angiogenesis, and healing in porcine full-thickness wounds. | 2008 Jan |
2 |
| 4 |
16242193 | Chemically modified tetracyclines (CMT-3 and CMT-8) enable control of the pathologic remodellation of human aortic valve stenosis via MMP-9 and VEGF inhibition. | 2006 Aug 28 |
1 |
| 5 |
15289334 | HB-EGF is a potent inducer of tumor growth and angiogenesis. | 2004 Aug 1 |
1 |
| 6 |
11880187 | Tumor growth enhancing effects of vascular endothelial growth factor are associated with increased nitric oxide synthase activity and inhibition of apoptosis in human breast carcinoma xenografts. | 2002 May 8 |
2 |
| 7 |
9916127 | Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal. | 1999 Jan |
2 |
| 8 |
10485491 | Protein kinase C lies on the signaling pathway for vascular endothelial growth factor-mediated tumor development and angiogenesis. | 1999 Sep 1 |
6 |
| 9 |
9238051 | Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal. | 1997 Aug 5 |
2 |
| 10 |
9307273 | Vascular endothelial growth factor is essential for initial but not continued in vivo growth of human breast carcinoma cells. | 1997 Sep 15 |
2 |